Trial NCT02680847

View at ClinicalTrials.gov 
Org. Study IDs: B4531015
Secondary IDs: ALO-02 PHASE 4 PEDIATRIC STUDY

Last trial update was posted on 2018-09-25

MeSH Interventions

Naltrexone Oxycodone

MeSH Conditions


Other Conditions

Moderate-severe Pain

Stopping Reasons

The trial was terminated on 08FEB2018. Pfizer has decided to withdraw the New Drug Application and has notified FDA. There are no efficacy or safety concerns.

Limitations And Caveats

The study was terminated due to sponsor's decision instead of safety or efficacy reasons. Early termination led to small numbers of participants summarized or described and PK samples were not analyzed.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID